Renal cell carcinoma (RCC) had historically been regarded as a disease that was refractory to therapy once surgical options had been exhausted.
Edwin M. Posadas, MD, FACP
Advertisement
Articles by Edwin M. Posadas, MD, FACP
Advertisement
Latest Updated Articles
- Systemic Therapy in Renal Cell Carcinoma: Advancing Paradigms
Published: March 15th 2012 | Updated:
Advertisement
Advertisement
Trending on CGTlive®
1
Around the Helix: Cell and Gene Therapy Company Updates – December 3, 2025
2
FDA Activity Recap: November 2025 Features SMA Approval, Boxed Warning for Elevidys, and More
3
Lessons Learned From the Past 25 Years of Cell and Gene Therapy Research
4
Key Unknowns Remain in Cell and Gene Therapy
5
